Cargando…
A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma
More and more clinical trials have tried to assess the clinical benefit of anti-interleukin (IL)-13 monoclonal antibodies for uncontrolled asthma. The aim of this study is to evaluate the efficacy and safety of anti-IL-13 monoclonal antibodies for uncontrolled asthma. Major databases were searched f...
Autores principales: | Li, Hang, Wang, Kai, Huang, Huiting, Cheng, Wenbin, Liu, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355027/ https://www.ncbi.nlm.nih.gov/pubmed/30703143 http://dx.doi.org/10.1371/journal.pone.0211790 |
Ejemplares similares
-
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
por: Oh, Chad K, et al.
Publicado: (2013) -
Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
por: Casas-Maldonado, Francisco, et al.
Publicado: (2023) -
A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
por: Agumadu, Vivian C, et al.
Publicado: (2018) -
Azithromycin as an add-on treatment for persistent uncontrolled asthma in adults: protocol of a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2020) -
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma
por: May, RD, et al.
Publicado: (2012)